Background Biomarkers have been proposed as tools to aid in the identification and
prognostication of interstitial lung disease (ILD) in rheumatoid arthritis (RA). We performed a …

Objective To evaluate the associations of plasma matrix metalloproteinases (MMPs) with
prevalent and incident interstitial lung disease (ILD) in people with rheumatoid arthritis (RA) …

Background: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is an
important extra-articular manifestation of rheumatoid arthritis (RA). Identifying patients at risk …

Background Rheumatoid arthritis (RA)-associated interstitial lung disease (ILD) is common
in patients with RA and leads to significant morbidity and mortality. No randomized, placebo …

Objective The objective of this study is to determine the associations of protein‐specific anti–
malondialdehyde‐acetaldehyde (MAA) antibodies with prevalent and incident rheumatoid …

Objectives To explore the course of lung function and RA disease activity and predictive
factors for deteriorating lung function in patients with RA-interstitial lung disease (ILD) …

Objective We aimed to evaluate lung cancer risk in patients with rheumatoid arthritis (RA)
and RA‐interstitial lung disease (ILD). Methods We performed a retrospective, matched …

Objectives To describe comorbid conditions in patients with rheumatoid arthritis–associated
interstitial lung disease (RA-ILD) and to analyze factors associated with multimorbidity …

Objectives Interstitial lung disease (ILD) is a severe extra-articular manifestation of
rheumatoid arthritis (RA). The objectives of this study were to estimate mortality rate in …

Background and objectives Preclinical interstitial lung disease (pILD) may represent the
early stages of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). However …